We achieved our first quarter of positive GAAP net income in Q4 at $5 million, and we delivered positive full-year adjusted EBITDA of $6 million
Non-surgical treatments work best for: Surgery may be needed for: Body areas that respond well to non-surgical treatment: Body areas that often need surgery: An honest assessment is essential
While he notes Novo Nordisk's pill as "important" to consumers, it's Eli Lilly's injectable he sees continuing to lead GLP-1 momentum
The 28.7% average weight loss observed in TRIUMPH 4 places this medication in a category of its own, which should strengthen the case for expedited review
That means there is no standardized retail price, no insurance coverage, and no pharmacy benefit manager negotiating rates on your behalf
In Australia in 2023, there were approximately 2.5 million prescriptions for Semaglutide alone under the Pharmaceutical Benefits Scheme, which is nearly double the previous years total prescription 12